Press release
Global Factors Influencing the Rapid Evolution of the Mosquito Borne Diseases Market
Mosquito Borne Diseases Market
Forecasted Market Size Growth for Mosquito Borne Diseases by 2030
The market for mosquito borne diseases is anticipated to experience substantial growth in the coming years. It is projected to reach a value of $4.81 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.8%. This expansion is driven by several factors, including the introduction of new genetic control technologies, the broadening of vaccination initiatives worldwide, and increased funding directed toward global health efforts. Additionally, the rapid adoption of digital disease surveillance tools and a growing demand for advanced mosquito control products are key contributors to this growth. Notable trends expected to influence the market include the rising uptake of precision vector surveillance systems, greater implementation of AI-powered models for predicting disease outbreaks, expansion of IoT-enabled mosquito monitoring technologies, a push toward environmentally sustainable vector control solutions, and the integration of digital health platforms to facilitate remote disease tracking.
Download a free report of the mosquito borne diseases market report:
https://www.thebusinessresearchcompany.com/report/mosquito-borne-diseases-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Companies Influencing the Mosquito Borne Diseases Market
Several prominent companies play significant roles in the mosquito borne diseases market. These include Johnson & Johnson, Merck & Co Inc, Sanofi SA, Novartis AG, GlaxoSmithKline plc, Serum Institute of India Pvt Ltd, Emergent BioSolutions, Valneva SE, Bharat Biotech, Syngenta, Orkin Inc, RTI International, Vector Control International, Clarke Environmental Mosquito Management, Oxitec Ltd, Abbott Laboratories, Takeda Pharmaceuticals, Sun Pharmaceutical Industries Ltd, Pfizer Inc, Roche Holding AG, Moderna Inc, BioNTech SE, CSL Limited, Bayer AG, and BASF SE.
A notable collaboration took place in February 2024, when Japan's Kao Corporation partnered with Earth Corporation to address mosquito-borne diseases in Thailand. Together, they launched the ARS Mos Shooter, an eco-friendly spray that combines advanced surfactant technology with lemongrass essential oil to disrupt mosquito flight. This community-focused initiative aims to curb the spread of dengue fever by promoting public health awareness and engagement. Earth Corporation, also based in Japan, specializes in household products and insecticides and is actively involved in combating mosquito-borne infections.
View the full mosquito borne diseases market report:
https://www.thebusinessresearchcompany.com/report/mosquito-borne-diseases-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Emerging Trends Supporting the Mosquito Borne Diseases Market's Growth
Innovations in safety and technology are positively impacting the market. Companies are focusing on developing improved safety features for medical devices to reduce risks associated with disease transmission and occupational hazards. A good example is the launch of new safety-enhanced injection solutions designed to protect healthcare workers from needlestick injuries and minimize infection risks.
In April 2024, Hindustan Syringes and Medical Devices, an Indian medical device manufacturer, introduced Dispojekt Syringes. This product incorporates a transparent, one-handed safety mechanism and a molded plastic shield to prevent blood splatter, significantly lowering accidental needlestick injury rates in clinical settings. Through such advancements, companies are addressing critical safety concerns while contributing to the broader goal of elevating healthcare standards and medical device manufacturing capabilities in India.
Mosquito Borne Diseases Market Segmentation Overview
The mosquito borne diseases market can be categorized into several key segments for a more detailed understanding. These include:
1) Disease Type: This comprises Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus, and other diseases.
2) Treatment Type: Segments here include Medication, Vaccination, Vector Control Methods, Immunotherapy, Supportive Care, and others.
3) End User: Important end users consist of Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, Non-Governmental Organizations, among others.
Further breakdowns within disease categories provide more specificity:
- Malaria is divided into Plasmodium Falciparum and Plasmodium Vivax types.
- Dengue is segmented into Dengue Fever and Severe Dengue (also known as Dengue Hemorrhagic Fever).
- Yellow Fever includes Acute and Chronic Yellow Fever.
- West Nile Virus is split between Neuroinvasive Disease (such as Encephalitis and Meningitis) and Non-neuroinvasive Disease.
- Chikungunya is categorized into Acute and Chronic forms.
- Zika Virus includes Acute Zika Infection and Congenital Zika Syndrome.
- Other diseases cover Japanese Encephalitis, La Crosse Encephalitis, and Eastern Equine Encephalitis (EEE).
This segmentation ensures a comprehensive perspective on how varied diseases and treatment approaches contribute to the overall market landscape.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Factors Influencing the Rapid Evolution of the Mosquito Borne Diseases Market here
News-ID: 4483226 • Views: …
More Releases from The Business Research Company
Market Driver Insights: The Impact of Recent Advancements on the Periodontal Dis …
The periodontal disease treatment market is on track for significant expansion in the coming years. With innovations in treatment methods and growing awareness among patients, this sector is preparing to meet increasing demand and evolving healare needs. Let's explore the market's current size, key drivers, prominent players, future trends, and segmentation details to understand the trajectory of this important healare field.
Projected Growth and Market Size of the Periodontal Disease Treatment…
Peptic Ulcer Market Overview: Major Segments, Strategic Developments, and Leadin …
The peptic ulcer market is positioned for consistent advancement as healare innovations and treatment accessibility continue to improve. With ongoing developments in diagnostic tools and therapeutic options, this sector is expected to witness steady expansion over the coming years. Here is a detailed overview of the market's valuation, key players, driving trends, and segment insights shaping its future.
Projected Market Valuation and Growth Trajectory of the Peptic Ulcer Market
The peptic…
Segmentation, Major Trends, and Competitive Overview of the Pelvic Inflammatory …
The pelvic inflammatory disease (PID) treatment market is gearing up for notable expansion in the coming years. With advancements in medical therapies and growing awareness around early diagnosis, this market is set to experience steady growth and evolving treatment strategies. Let's explore the forecasted market size, key players, influential trends, and market segmentation to better understand what lies ahead.
Projected Expansion and Market Size of the Pelvic Inflammatory Disease Treatment Industry…
Leading Companies Fueling Growth and Innovation in the Pediatric Neuroblastoma T …
The pediatric neuroblastoma treatment market is poised for significant expansion as advancements in medical research and technology continue to accelerate. With a focus on innovative therapies and improved patient care, this sector is expected to experience robust growth in the coming years. Below is a detailed overview of the market's size, key players, driving factors, and emerging trends shaping its future.
Pediatric Neuroblastoma Treatment Market Size and Growth Outlook
The market…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
